Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables

DOI10.1002/BIMJ.201100221MaRDI QIDQ2919476zbMATH OpenOpenAlexWikidataFDO

Authors Takashi Sozu, Tomoyuki Sugimoto, Toshimitsu Hamasaki

Publication date 2 October 2012

Published in Biometrical Journal (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1002/bimj.201100221

zbMATH Keywords

latent variablemultiplicitymultivariate normalbiserial correlationintersection-union test

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Sample size determination in clinical trials with multiple endpoints
• Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints
• Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints
• Letter to the editor: Regarding paper ``Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables
• scientific article; zbMATH DE number 2204560

Cites work

• scientific article; zbMATH DE number 67146 (Why is no real title available?)
• Applications of Correlation Models for Biserial Data
• Correlated Binary Regression with Covariates Specific to Each Binary Observation
• Correlation Between a Discrete and a Continuous Variable. Point-Biserial Correlation
• On a multiple endpoints testing problem
• Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables
• Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints
• THE THEORY OF CORRELATION BETWEEN TWO CONTINUOUS VARIABLES WHEN ONE IS DICHOTOMIZED
• The Point Biserial Coefficient of Correlation

Cited in

(10)

• Sample size determination in clinical trials with multiple endpoints
• Power analyses for stepped wedge designs with multivariate continuous outcomes
• Letter to the editor: Regarding paper ``Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables
• Sample size determination and re-estimation for matched pair designs with multiple binary endpoints
• Assessing additional benefit in noninferiority trials
• Sample Size Requirements and Study Duration for Testing Main Effects and Interactions in Completely Randomized Factorial Designs When Time to Event is the Outcome
• Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables
• Power analysis for cluster randomized trials with multiple binary co‐primary endpoints
• Sample size estimation using a latent variable model for mixed outcome co-primary, multiple primary and composite endpoints
• A simple procedure to estimate the optimal sample size in case of conjunctive coprimary endpoints

Describes a project that uses

Uses Software

• QSIMVN

This page was built for publication: Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2919476)